The Study was designed to look at the safety and efficacy of abatacept in combination with etanercept.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
141
Abatacept combined with etanercept will have greater clinical efficacy compared to subjects receiving etanercept alone
Time frame: at 6 months
ACR 50 and 70 will be evaluated
Time frame: at 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Local Institution
Huntsville, Alabama, United States
Local Institution
La Jolla, California, United States
Local Institution
Long Beach, California, United States
Local Institution
Los Angeles, California, United States
Local Institution
Palo Alto, California, United States
Local Institution
San Francisco, California, United States
Local Institution
Denver, Colorado, United States
Local Institution
Fort Lauderdale, Florida, United States
Local Institution
Titusville, Florida, United States
Local Institution
Rome, Georgia, United States
...and 25 more locations